DR

Dullabhbhai Ranchhodji Patel

Active Director Director DIN 08282634
DIN 08282634 First appointment Nov 2018 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Dullabhbhai Ranchhodji Patel

Data last updated:

Dullabhbhai Ranchhodji Patel is a Director at Rinbha Pharmaceuticals Private Limited (since 2018). The company operates in Food And Beverages.

DIN 08282634
Primary Designation Director
Industry Food And Beverages
First Appointment 19 Nov 2018
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Nov 20182018Active

Board colleagues of Dullabhbhai Ranchhodji Patel

NameDINCompanyDesignation
Rina Bhadresh Patel08282633Rinbha Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rinbha Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Dullabhbhai Ranchhodji Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dullabhbhai Ranchhodji Patel

Dullabhbhai Ranchhodji Patel currently holds 1 directorship: Rinbha Pharmaceuticals Private Limited (Director, since 19 Nov 2018).

Dullabhbhai Ranchhodji Patel was first appointed on 19 Nov 2018 as Director at Rinbha Pharmaceuticals Private Limited.

The current boards of Dullabhbhai Ranchhodji Patel's companies include Rina Bhadresh Patel (Rinbha Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available